Seeking Alpha

Invitrogen Corp. (IVGN)

()

Comments on IVGN

  • Reversal of Stem Cell Research Ban: 13 Stocks to Benefit [View article]
    KOOL is the one to own now, a 5-10 bagger in a year or so, in my humble opinion.
    Comment by kool
    Jul 29 20:10 pm |
    Rating: 0 0
  • Investing in Stem Cell Stocks: Growth Industry of the Future? [View article]
    Informative post, thanks..
    Jun 13 18:39 pm |
    Rating: 0 0
  • Investing in Stem Cell Stocks: Growth Industry of the Future? [View article]
    I made $2 million in 3 months in 2001 just before the bust. Had I still held the stock since then.....my Amgen, Biogen, etc would have... More »
    Comment by Ron Diamond
    May 16 02:17 am |
    Rating: 0 0
  • Investing in Stem Cell Stocks: Growth Industry of the Future? [View article]
    Stem cells are promising in research rather lot has already been explored though still its a long way. Since they can acquire... More »
    Comment by Health Expert
    May 8 09:52 am |
    Rating: 0 0
  • A Look at D.E. Shaw's Q408 Holdings: Just for Fun [View article]
    the increase in aapl is smart. Even after its runup, the stock still looks like it's in a good long-term... More »
    Comment by mysteryleo
    May 3 08:09 am |
    Rating: 0 0
  • A Look at D.E. Shaw's Q408 Holdings: Just for Fun [View article]
    He's going to lose his shirt on those Apple Puts... very risky to Put Apple right now.... good for us that are long, though. Most of... More »
    Comment by winindthedust
    Apr 22 10:57 am |
    Rating: +1 0
  • Reversal of Stem Cell Research Ban: 13 Stocks to Benefit [View article]
    I wouldn't hold my breath. Don't waste a whole lot of money on this gamble. I bought in to the hype with gern at $6 and I'm not... More »
    Comment by Titus Andronicus
    Apr 8 16:59 pm |
    Rating: +3 0
  • Reversal of Stem Cell Research Ban: 13 Stocks to Benefit [View article]
    KOOL Thermogenics, little debt, cash flow, specialty service and equipement to stem cell industry, with unique products and long term... More »
    Comment by John Cordes
    Mar 13 09:31 am |
    Rating: 0 0
  • Reversal of Stem Cell Research Ban: 13 Stocks to Benefit [View article]
    By bringing it up 3 times in the first 4 paragraphs, I must assume the author felt a real compulsion to get his political viewpoint... More »
    Comment by Mr. Ed, Jr.
    Mar 13 03:32 am |
    Rating: 0 0
  • Reversal of Stem Cell Research Ban: 13 Stocks to Benefit [View article]
    Stem-cell research maybe just a way of wasting taxpayers' money after all. So far heard nothing exciting about it. This has been talks... More »
    Comment by PeteK
    Mar 13 02:41 am |
    Rating: 0 -3
  • Reversal of Stem Cell Research Ban: 13 Stocks to Benefit [View article]
    Will someone tell this author to do his homework and stop pumping Ariad Pharma. This stock is not a stem-cell stock, but merely a... More »
    Comment by cposch
    Mar 12 10:31 am |
    Rating: +1 0
  • Reversal of Stem Cell Research Ban: 13 Stocks to Benefit [View article]
    This list is a little too broad. Really there are are only 3 companies that "directly" benefit from the ban: GERN, ACT.PK, and BTIM. ... More »
    Comment by rlwinvestor
    Mar 12 09:35 am |
    Rating: +1 0
  • Reversal of Stem Cell Research Ban: 13 Stocks to Benefit [View article]
    The only stem cell stock worth investing is Thermogenesis (KOOL) and actually an excellent investment for years to come, why? Not... More »
    Comment by stox
    Mar 12 06:08 am |
    Rating: +1 0
  • Reversal of Stem Cell Research Ban: 13 Stocks to Benefit [View article]
    under bush, America has given up an 8 year research lead to asia and europe. i would welcome an article quantifying how behind we are.
    Comment by Steven Hansen
    Mar 12 04:44 am |
    Rating: +2 -1
  • Hedge Fund Tracking: Barry Rosenstein's Jana Partners, Q3 2008 [View article]
    i was digging around looking for info on some crazy ticker, and who do i find has a post up on it? whatupppp, Folly? you still have on... More »
    Comment by Jim Punkrockford
    Feb 18 07:01 am |
    Rating: +2 0